| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 160033-52-3 | (2S,5R)-N-Boc-5-甲基吡咯烷-2-甲酸; (2S,5R)-N-叔丁氧羰基-5-甲基吡咯烷-2-甲酸 | (2S,5R)-N-Boc-5-methylpyrrolidine-2-carboxylic acid; (2S,5R)-1-(tert-Butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid; (2S,5R)-5-Methyl-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) ester |  | C11H19NO4 | 詳情 | 供應(yīng)商 |
| 334769-80-1 | (2S,5S)-N-Boc-5-甲基吡咯烷-2-甲酸; (2S,5S)-N-叔丁氧羰基-5-甲基吡咯烷-2-甲酸 | (2S,5S)-N-Boc-5-methylpyrrolidine-2-carboxylic acid; (2S,5S)-1-(tert-Butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid; (2S,5S)- 5-Methyl-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) ester |  | C11H19NO4 | 詳情 | 供應(yīng)商 |
| 374929-20-1 | (2S)-N-Boc-5-甲基吡咯烷-2-甲酸; (2S)-N-叔丁氧羰基-5-甲基吡咯烷-2-甲酸 | (2S)-N-Boc-5-methylpyrrolidine-2-carboxylic acid; (2S)-1-(tert-Butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid; (2S)-5-Methyl-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) ester |  | C11H19NO4 | 詳情 | 供應(yīng)商 |
| 649735-46-6 | 酪氨酸激酶抑制劑; 1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2- | 1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propan; 1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol; Brivanib; Tyrosine Kinase Inhibitor; (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yloxy)propan-2-ol; 2-Propanol, 1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)oxy)-, (2R)-; Bms 540215; Bms540215; Unii-ddu33B674i |  | C19H19FN4O3 | 詳情 | 供應(yīng)商 |
| 1108234-23-6 | (3R,5S)-5-甲基吡咯烷-3-醇 | (3R,5S)-5-Methylpyrrolidin-3-ol | 無 | 詳情 | 供應(yīng)商 |